Sherman Baker

5.4k total citations · 4 hit papers
16 papers, 3.6k citations indexed

About

Sherman Baker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Sociology and Political Science. According to data from OpenAlex, Sherman Baker has authored 16 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Sociology and Political Science. Recurrent topics in Sherman Baker's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Family Support in Illness (4 papers). Sherman Baker is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Family Support in Illness (4 papers). Sherman Baker collaborates with scholars based in United States and Canada. Sherman Baker's co-authors include Thomas J. Smith, John R. Strawn, Christopher G. Azzoli, David G. Pfister, David H. Johnson, Joan H. Schiller, Gregory A. Masters, Sarah Temin, Giuseppe Giaccone and Julie R. Brahmer and has published in prestigious journals such as Journal of Clinical Oncology, Psycho-Oncology and Journal of Thoracic Oncology.

In The Last Decade

Sherman Baker

15 papers receiving 3.5k citations

Hit Papers

American Society of Clinical Oncology Treatment of Unrese... 2003 2026 2010 2018 2003 2009 2015 2017 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
    2003 1.2k citations David G. Pfister, David H. Johnson et al. Journal of Clinical Oncology profile →
  2. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
    2009 752 citations Christopher G. Azzoli, Sherman Baker et al. Journal of Clinical Oncology profile →
  3. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
    2015 695 citations Gregory A. Masters, Sarah Temin et al. Journal of Clinical Oncology profile →
  4. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 471 citations Nasser H. Hanna, David H. Johnson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherman Baker United States 10 2.7k 2.4k 647 471 224 16 3.6k
Thierry Jahan United States 28 1.8k 0.7× 1.8k 0.7× 680 1.1× 290 0.6× 215 1.0× 79 3.5k
Jason A. Wampfler United States 28 1.8k 0.7× 1.7k 0.7× 586 0.9× 350 0.7× 184 0.8× 65 3.0k
Olivier Molinier France 20 2.6k 1.0× 2.5k 1.0× 477 0.7× 463 1.0× 143 0.6× 87 3.5k
Giannis Mountzios Greece 30 971 0.4× 1.6k 0.6× 1.0k 1.6× 507 1.1× 189 0.8× 124 3.2k
Leora Horn United States 32 2.4k 0.9× 3.2k 1.3× 777 1.2× 569 1.2× 284 1.3× 128 4.3k
Pilar Garrido Spain 31 1.9k 0.7× 2.1k 0.9× 909 1.4× 610 1.3× 290 1.3× 291 3.9k
Paolo Maione Italy 31 2.0k 0.7× 2.2k 0.9× 1.1k 1.7× 452 1.0× 141 0.6× 138 3.6k
Masashi Ando Japan 31 954 0.3× 2.0k 0.8× 688 1.1× 774 1.6× 361 1.6× 206 3.6k
Alicia K. Morgans United States 29 1.9k 0.7× 1.1k 0.4× 557 0.9× 429 0.9× 422 1.9× 202 3.4k
Roman Gulati United States 34 2.3k 0.8× 1.6k 0.6× 672 1.0× 662 1.4× 304 1.4× 128 3.6k

Countries citing papers authored by Sherman Baker

Since Specialization
Citations

This map shows the geographic impact of Sherman Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherman Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherman Baker more than expected).

Fields of papers citing papers by Sherman Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherman Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherman Baker. The network helps show where Sherman Baker may publish in the future.

Co-authorship network of co-authors of Sherman Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Sherman Baker. A scholar is included among the top collaborators of Sherman Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherman Baker. Sherman Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Hanna, Nasser H., David H. Johnson, Sarah Temin, et al.. (2017). Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 35(30). 3484–3515. 471 indexed citations breakdown →
3.
Dragoescu, Ema, Christopher A. French, Anthony Cassano, Sherman Baker, & Weldon Chafe. (2015). NUT Midline Carcinoma Presenting With Bilateral Ovarian Metastases. International Journal of Gynecological Pathology. 34(2). 136–142. 3 indexed citations
4.
Masters, Gregory A., Sarah Temin, Christopher G. Azzoli, et al.. (2015). Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 33(30). 3488–3515. 695 indexed citations breakdown →
5.
Socinski, Mark A., Xiaofei F. Wang, Maria Q. Baggstrom, et al.. (2014). Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.. Journal of Clinical Oncology. 32(15_suppl). 8040–8040. 7 indexed citations
6.
Siminoff, Laura A., Lindsey Dorflinger, Amma A. Agyemang, Sherman Baker, & Maureen Wilson-Genderson. (2012). Oncologists’ assessments of lung cancer patient and family disagreements regarding treatment decision making. Lung Cancer. 77(1). 212–216. 20 indexed citations
7.
Azzoli, Christopher G., Sarah Temin, Timothy Aliff, et al.. (2011). 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(28). 3825–3831. 234 indexed citations
8.
Hoskins, Carol Noll & Sherman Baker. (2011). Adjustment among spouses of women with breast cancer.
9.
Siminoff, Laura A., Maureen Wilson‐Genderson, & Sherman Baker. (2010). Depressive symptoms in lung cancer patients and their family caregivers and the influence of family environment. Psycho-Oncology. 19(12). 1285–1293. 95 indexed citations
10.
Azzoli, Christopher G., Sherman Baker, Sarah Temin, et al.. (2010). [American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].. PubMed. 13(3). 171–89. 48 indexed citations
11.
Azzoli, Christopher G., Sherman Baker, Sarah Temin, et al.. (2009). American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(36). 6251–6266. 752 indexed citations breakdown →
12.
Clark, Allan, et al.. (2009). Primary brain T-cell lymphoma of the lymphoblastic type presenting as altered mental status. Acta Neurochirurgica. 152(1). 163–168. 5 indexed citations
13.
Pfister, David G., David H. Johnson, Christopher G. Azzoli, et al.. (2003). American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003. Journal of Clinical Oncology. 22(2). 330–353. 1169 indexed citations breakdown →
14.
Baker, Sherman, Deborah Witt Sherman, Marilyn Bookbinder, et al.. (1996). Social Support and Patterns of Adjustment to Breast Cancer. Research and Theory for Nursing Practice. 10(2). 99–123. 55 indexed citations
15.
Baker, Sherman, et al.. (1992). As breast cancer rates rise, nurses' role increases.. PubMed. 19(6). 1, 6–9. 1 indexed citations
16.
Baker, Sherman. (1979). Acute epiglottitis: a continuing challenge.. PubMed. 58(6). 268–73. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thierry Jahan Breakdown of academic impact, for papers by Jason A. Wampfler Breakdown of academic impact, for papers by Olivier Molinier Breakdown of academic impact, for papers by Giannis Mountzios Breakdown of academic impact, for papers by Leora Horn Breakdown of academic impact, for papers by Pilar Garrido Breakdown of academic impact, for papers by Paolo Maione Breakdown of academic impact, for papers by Masashi Ando Breakdown of academic impact, for papers by Alicia K. Morgans Breakdown of academic impact, for papers by Roman Gulati
Rankless by CCL
2026